Edwards Lifesciences Corp Congressional Trading
According to U.S. congressional financial disclosures filed under the STOCK Act, members of Congress have reported 126 trades in Edwards Lifesciences Corp (NYSE: EW) since 2014, across 22 members, worth an estimated $1.4M in disclosed volume (the midpoint of the dollar ranges members report, not exact amounts). 68 buys against 58 sells, a modestly buy-led skew, with Democratic members responsible for 48% of the trades and Republican members 52%. The most recent disclosure shown was filed July 2026, and Rohit Khanna has filed the most EW transactions among those shown, with 12. Other recent filers include Alan Armstrong and Josh Gottheimer. One notable disclosed move was a purchase by Rohit Khanna on April 13, 2026, up 16.3% since. These figures are drawn from public House and Senate periodic transaction reports and reflect what members were required to disclose, not the current market value of any position. For the full record, including the month-by-month buy and sell timeline, the party breakdown, top buyers and sellers, and every individual filing, see the Edwards Lifesciences Corp (EW) stock overview and the complete trade table below.
Data updated
Price & congressional trade timeline
Party breakdown
Edwards Lifesciences congressional trading activity
| Politician | Published | Traded | Filed After | Type | Size | Return | Owner | |
|---|---|---|---|---|---|---|---|---|
 Rohit Khanna House | Jun 9, 2026 | May 27, 2026 | 13 days | BUY |  $1,001 - $15,000 | +5.04% | Spouse | |
Rohit Khanna House | Jun 9, 2026 | May 15, 2026 | 25 days | BUY | $1,001 - $15,000 | +11.66% | Spouse | |
Rohit Khanna House | Jun 9, 2026 | May 1, 2026 | 39 days | BUY | $1,001 - $15,000 | +8.20% | Child | |
Rohit Khanna House | May 11, 2026 | Apr 24, 2026 | 17 days | SELL | $1,001 - $15,000 | +7.99% | Spouse | |
Rohit Khanna House | May 11, 2026 | Apr 13, 2026 | 28 days | BUY | $1,001 - $15,000 | +16.32% | Spouse | |
Rohit Khanna House | Apr 7, 2026 | Mar 30, 2026 | 8 days | SELL | $1,001 - $15,000 | +14.30% | Child | |
 Alan Armstrong Senate | Jul 21, 2026 | Mar 27, 2026 | 116 days | BUY | $1,001 - $15,000 | +14.53% | Self | |
Rohit Khanna House | Apr 7, 2026 | Mar 23, 2026 | 15 days | BUY | $1,001 - $15,000 | +10.79% | Spouse | |
Rohit Khanna House | Mar 9, 2026 | Feb 5, 2026 | 32 days | SELL | $1,001 - $15,000 | +16.35% | Spouse | |
Rohit Khanna House | Feb 6, 2026 | Jan 29, 2026 | 8 days | BUY | $1,001 - $15,000 | +11.51% | Spouse |
Edwards Lifesciences (EW) congressional trading FAQ
Can members of Congress legally trade Edwards Lifesciences (EW) stock?
Yes. Members of Congress are permitted to trade individual stocks, including Edwards Lifesciences (EW), but the STOCK Act of 2012 requires them to publicly disclose each transaction within 45 days. Quantellect tracks those disclosures; it does not imply any trade was improper.
Are congressional Edwards Lifesciences (EW) trades public?
Yes. Every congressional trade in Edwards Lifesciences (EW) on this page comes from mandatory public STOCK Act disclosure filings, which are filed with a delay and may be revised.
How many times has Congress traded Edwards Lifesciences (EW)?
Members of Congress have disclosed 126 trades in Edwards Lifesciences (EW) worth $1.4M across 22 members, according to public STOCK Act filings.
Which members of Congress have traded Edwards Lifesciences (EW)?
Recent and active filers of Edwards Lifesciences (EW) disclosures include Rohit Khanna, Alan Armstrong, Josh Gottheimer. The full member-by-member trade list is on this page.
Do Democrats or Republicans trade Edwards Lifesciences (EW) more?
Across disclosed Edwards Lifesciences (EW) trades, 48% were by Democrats and 52% by Republicans, led by Republicans (52%).
What is the most recent congressional Edwards Lifesciences (EW) trade?
The most recent disclosed Edwards Lifesciences (EW) trade was a purchase by Alan Armstrong, filed Jul 20, 2026.
Browse all stocks Congress tradesCongressional trading overviewEdwards Lifesciences (EW) stock overview
Not investment advice. Congressional trading data is sourced from public STOCK Act disclosures, which are filed with a delay and may contain errors or be revised. The Tide Score and other figures are generated algorithmically from public filings and market data and describe historical activity, not a recommendation. Always do your own research and consult a licensed financial advisor before making investment decisions.